AP NEWS

OncLive® to Host State of the Science Summit™ on Treatment of Hematologic Malignancies

October 9, 2018

CRANBURY, N.J.--(BUSINESS WIRE)--Oct 9, 2018--OncLive®, the leading digital provider of resources and information to oncology professionals, presents the latest State of the Science Summit™ on the treatment of hematologic malignancies on Thursday, Oct. 18 from 5 to 9 p.m. (CDT) at the Clayton Plaza Hotel in Missouri. The summit will be co-chaired by experts from the Washington University School of Medicine in St. Louis: Brad S. Kahl, M.D., professor, department of medicine, division of medical oncology and Ravi Vij, M.D., MBA, professor, department of medicine, division of oncology bone marrow transplantation and leukemia.

Designed for community oncologists interested in the treatment of patients with hematologic malignancies. this education program delves into chronic lymphocytic leukemia (CLL), lymphoma, multiple myeloma, chronic myeloid leukemia, acute myeloid leukemia, treatment of myelofibrosis/polycythemia Vera and the latest updates on CAR-T. The event will also feature a peer exchange, which will be followed by a panel discussion and question-and-answer session.

Presenters from the Washington University School of Medicine in St. Louis include:

Nancy L Bartlett, M.D., professor, department of medicine, division of medical oncology Armin Ghobadi, M.D., assistant professor, department of medicine, oncology division of bone marrow transplantation and leukemia Meagan A. Jacoby, M.D., assistant professor, department of medicine, oncology division of bone marrow transplantation and leukemia Stephen Oh, M.D., PhD, assistant professor, department of medicine, hematology division, department of pathology and immunology Mark A. Schroeder, M.D., assistant professor, department of medicine, oncology division of bone marrow transplantation and leukemia Geoffrey L. Uy, M.D., associate professor, department of medicine, oncology division of bone marrow transplantation and leukemia

State of the Science Summit™ is a premier conference series, hosted by OncLive®, that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.

Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit https://www.onclive.com/meetings/soss or contact Kayla Collins at kcollins@curetoday.com.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive ®, Oncology Nursing News ® and more. MJH Associates Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE ® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE ® reaches patients, cancer centers and advocacy groups.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181009005804/en/

CONTACT: OncLive® Media:

Alexandra Ventura, 609-716-7777, ext. 121

aventura@mjhassoc.com

or

John Patricolo, 609-325-4630

jpatricolo@mjhassoc.com

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: HEALTH ONCOLOGY OTHER HEALTH RESEARCH OTHER SCIENCE SCIENCE

SOURCE: OncLive®

Copyright Business Wire 2018.

PUB: 10/09/2018 10:45 AM/DISC: 10/09/2018 10:45 AM

http://www.businesswire.com/news/home/20181009005804/en

AP RADIO
Update hourly